Capital Markets Day - December 16th, 2024, QEII Centre, Westminster, London
Time
Agenda
8:00 - 8:30
Breakfast & coffee
8:30 - 8:50
President & CEO Kari E. Krogstad
Next steps and innovations for accelerated growth
Next steps and innovations for accelerated growth
8:50 - 9:00
Product & Business Manager Tore Skjeggestad
Introducing INTUI - our newly launched software platform – an intuitive solution optimized to provide data interpretation guidance and enhancing surgical decision-making for better patient outcomes
Introducing INTUI - our newly launched software platform – an intuitive solution optimized to provide data interpretation guidance and enhancing surgical decision-making for better patient outcomes
9:00 - 9:15
Prof. John D. Puskas
A heart surgeon’s perspective on the future of coronary revascularization in light of endovascular alternatives, CT-FFR techniques and new medication. Why does INTUI matter?
A heart surgeon’s perspective on the future of coronary revascularization in light of endovascular alternatives, CT-FFR techniques and new medication. Why does INTUI matter?
9:15 - 9:30
Associate Prof. Gianluca Torregrossa
A perspective on educating the next generation of surgeons - how can INTUI help? My experience as an early access user
A perspective on educating the next generation of surgeons - how can INTUI help? My experience as an early access user
9:30 - 9:40
Q&A first session
9:40 - 9:50
VP Medical, Anne Waaler
Introduction to PATENT - a new clinical study on the use of TTFM in Peripheral Bypass surgery for treating critical limb-threatening ischemia (CLTI) patients
Introduction to PATENT - a new clinical study on the use of TTFM in Peripheral Bypass surgery for treating critical limb-threatening ischemia (CLTI) patients
9:50 - 10:00
Prof. Michael S. Conte (Video recording)
The lead investigator of the PATENT study on its importance and value
The lead investigator of the PATENT study on its importance and value
10:00 - 10:15
Prof. Maarit Venermo
Showcasing real-life examples and best practices on the use of TTFM in Peripheral Bypass surgery
Showcasing real-life examples and best practices on the use of TTFM in Peripheral Bypass surgery
10:15 - 10:20
Q&A second session
10:20 - 10:30
President & CEO Kari E. Krogstad
Q&A and closing remarks
Q&A and closing remarks